Advancing Breast Cancer Immunotherapy and Decoding Treatment Resistance with Dr. Hope Rugo
Jun 21st, 2022 by bcrf
What is triple-negative breast cancer and how is it identified? How can triple-negative breast cancers escape the immune system? And how can determining whether circulating tumor DNA in blood samples be used to predict metastatic breast cancer or treatment resistance in patients with aggressive disease?
BCRF investigator since 2007, Dr. Hope Rugo answers these questions and many more on the latest episode of Investigating Breast Cancer.